[eLD1] Shifting the Scales: Focus on Obesity and Managed Care Considerations
Pricing: Free for Members and $50 for Non-Members
Obesity has become a major public health concern in the United States, with a prevalence of 41.9% (2017) in adults and 19.7% (2020) in youth. There has been an increase in anti-obesity medication usage as patients have more therapy options, and new medications have greater efficacy and are generally more well tolerated. Increases in off-label weight loss usage of medications, particularly GLP-1 products, have created much discussion over the use of these products, their place in therapy, and how they are causing shifts across the industry.
This session will cover efficacy and safety comparisons of both medications with off-label weight loss usage and anti-obesity medications, the impact of increased off-label usage of GLP-1 products, and aspects of formulary decision-making regarding anti-obesity medications.
This knowledge-based activity has been designed to meet the educational needs of pharmacists in managed care settings.
At the completion of this activity, participants should be able to:
Summarize clinical efficacy and safety comparisons for medications used both on-label and off-label for weight loss.
Describe the impact of off-label weight loss use with GLP-1 products on different lines of business.
Discuss formulary decision-making regarding anti-obesity medications, including approaches, policies, and factors.
Justin Bioc, PharmD
Head of Clinical Pharmacy
Susan Downard, RPh
Director, Clinical Pharmacy
Michael Kaplan, DO
Chief Medical Officer
Long Island Weight Loss Institute
Amy Lugo, PharmD, BCPS, BC-ADM, FAPhA
Founder & CEO
LoneStar Health Solutions
Financial Relationship Disclosures:
|Faculty/Reviewer/Planner||Reported Relevant Financial Relationships|
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
- 1.00 ACPEThe Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.